Company news

Harrow, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Harrow Health to Announce Second Quarter 2021 Financial Results on August 10, 2021

July 25, 2021

NovaBay Pharmaceuticals Partners with Harrow Health’s ImprimisRx® to Promote Prescription Avenova

July 18, 2021

Harrow Health Granted Two Patents for Novel Surgical Dilation Formulation

July 14, 2021

Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026

June 16, 2021

Harrow Health Announces Pricing of $17.5 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026

June 13, 2021

Harrow Health Announces Offering of $17.5 Million of 8.625% Senior Notes Due 2026 and “BB” Rating from Egan-Jones

June 13, 2021

Visionology Acquires Exclusive Worldwide License to SPARCS Contrast Sensitivity Testing Technology

June 2, 2021

Harrow Health Launches New Corporate and Investor Website

May 31, 2021

Leading Peer-Reviewed Ophthalmic Journal Publishes Study on ImprimisRx’s Proprietary Klarity-C® Drops

May 16, 2021

Harrow Health Announces Record First Quarter 2021 Financial Results

May 10, 2021

Harrow Health Raises Approximately $11 Million in Sale of Series B Preferred Stock

May 4, 2021

Harrow Health Announces Full Exercise and Closing of Option to Purchase Additional Senior Notes

May 4, 2021

Harrow Health to Announce First Quarter 2021 Financial Results on May 11, 2021

April 26, 2021

Harrow Health Announces Closing of $50 Million Offering of Senior Notes Due 2026

April 19, 2021

Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026

April 14, 2021

Harrow Health Announces Preliminary First Quarter 2021 Financial Results

April 13, 2021

Harrow Health Announces Offering of $25 Million Senior Notes Due 2026 and “BB” Rating from Egan-Jones

April 13, 2021

Harrow Health Announces Fourth Quarter and Year-End 2020 Financial Results

March 7, 2021

Harrow Health to Participate in H.C. Wainwright Global Life Sciences Conference

March 1, 2021

Harrow Health to Announce Fourth Quarter and Year-End 2020 Financial Results on March 8, 2021

February 24, 2021

Study on Patented Non-Opioid MKO Melt® Reported in Leading Peer-Reviewed Anesthesia Journal

December 2, 2020

Harrow Health Announces Participation at the Piper Sandler 32nd Annual Healthcare Conference

November 19, 2020

Harrow Health Publishes Third Quarter 2020 Letter to Stockholders

November 8, 2020

Harrow Health to Announce Third Quarter 2020 Financial Results on November 9, 2020

October 26, 2020

Harrow Health Appoints Larry Van Horn to its Board of Directors

September 29, 2020

Harrow Health to Attend Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020

September 10, 2020

Harrow Health Publishes Second Quarter 2020 Letter to Stockholders

August 9, 2020

EyePoint Pharmaceuticals and Harrow Health’s ImprimisRx Announce U.S. Commercial Alliance for DEXYCU®

August 3, 2020

Harrow Health to Announce Second Quarter 2020 Financial Results on August 10, 2020

July 26, 2020

Leading Peer-Reviewed Journal Publishes Clinical Study on ImprimisRx’s Combination Prescription Eyedrops

July 12, 2020

Harrow Health Set to Join Russell 2000® Index and Russell 3000® Index

June 28, 2020

ImprimisRx’s Patented Klarity-C® 0.1% Cyclosporine Preservative-Free Formulation May Now Be Prescribed By Florida’s 2,000 Optometrists

June 17, 2020

Harrow Health Publishes First Quarter 2020 Letter to Stockholders

May 10, 2020

Harrow Health to Announce First Quarter 2020 Financial Results on May 11, 2020

April 26, 2020

ImprimisRx® Announces Exclusive Agreement with Doxy.me to Provide Healthcare Professionals with Telemedicine Services

March 23, 2020

Harrow Health Appoints Teresa Sparks to its Board of Directors

March 16, 2020

Harrow Health Publishes Fourth Quarter 2019 Letter to Stockholders

March 12, 2020

ImprimisRx® Announces Supply Agreement with EyeCare Services Partners

March 11, 2020

ImprimisRx® Announces Supply Agreement with iOR Partners

March 8, 2020

ImprimisRx® Announces Supply Agreement with Vision Center Network of America (VCNA)

March 2, 2020

Harrow Health to Announce Fourth Quarter 2019 Financial Results on March 13, 2020

February 26, 2020

ImprimisRx’s FDA-Registered Outsourcing Facility Issued California License

December 9, 2019

Harrow Health Publishes Third Quarter Letter to Stockholders

November 12, 2019

Harrow Health to Announce Third Quarter 2019 Financial Results on November 13, 2019

October 23, 2019

Mayfield Pharmaceuticals to Present at the SVB Leerink New Treatments Focused on Women’s Health Conference on October 10, 2019

October 7, 2019

ImprimisRx to Focus on Investments in Quality at the 2019 American Academy of Ophthalmology Meeting

October 7, 2019

← Newer news releases

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 57 decks. Every deck is listed under its year.